Nu Skin Enterprises (NUS) Tops Q3 EPS by 19c; Issues Weak Q4 Outlook

Go back to Nu Skin Enterprises (NUS) Tops Q3 EPS by 19c; Issues Weak Q4 Outlook

Nu Skin Enterprises (NUS) Can't Be Bought Until China Bottoms, Canaccord Genuity Says

November 5, 2014 10:38 AM EST

Canaccord Genuity analyst Scott Van Winkle weighed in on Nu Skin Enterprises (NYSE: NUS) following Q3 results and disappointing guidance, which has shares down 16% early. He said they are still waiting for a bottom and China and warned investors to stay... More

Nu Skin Enterprises (NUS) Buy Rating Maintained at Deutsche Bank

November 5, 2014 9:21 AM EST

Deutsche Bank maintained a Buy rating on Nu Skin Enterprises (NYSE: NUS) with a price target of $70. The stock declined sharply after it reported Q3 results.

Analyst Bill Schmitz Jr said, "While results were in-line on sales this quarter, weak 4Q guide and... More

Nu Skin Enterprises (NUS) Declares $0.345 Quarterly Dividend; 2.7% Yield

November 5, 2014 7:36 AM EST

Nu Skin Enterprises (NYSE: NUS) declared a quarterly dividend of $0.345 per share, or $1.38 annualized.

The dividend will be payable on December 3, 2014, to stockholders of record on November 21, 2014, with an ex-dividend date of November 19, 2014.

The annual yield on the dividend is 2.7... More

Heavily-Shorted Herbalife (HLF) Surges Ahead of Q3 Results

November 3, 2014 10:04 AM EST

In addition to settling a class action suit, speculators are bidding up (+6.5%) heavily-shorted Herbalife (NYSE:... More